| piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells K Woltjen, IP Michael, P Mohseni, R Desai, M Mileikovsky, R Hämäläinen, ... nature 458 (7239), 766-770, 2009 | 2371 | 2009 |
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors K Kaji, K Norrby, A Paca, M Mileikovsky, P Mohseni, K Woltjen Nature 458 (7239), 771-775, 2009 | 1754 | 2009 |
| Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming P Samavarchi-Tehrani, A Golipour, L David, H Sung, TA Beyer, A Datti, ... Cell stem cell 7 (1), 64-77, 2010 | 1124 | 2010 |
| Robust in vitro induction of human germ cell fate from pluripotent stem cells K Sasaki, S Yokobayashi, T Nakamura, I Okamoto, Y Yabuta, K Kurimoto, ... Cell stem cell 17 (2), 178-194, 2015 | 488 | 2015 |
| Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation K Ohnishi, K Semi, T Yamamoto, M Shimizu, A Tanaka, K Mitsunaga, ... Cell 156 (4), 663-677, 2014 | 461 | 2014 |
| An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming M Gabut, P Samavarchi-Tehrani, X Wang, V Slobodeniuc, D O'Hanlon, ... Cell 147 (1), 132-146, 2011 | 423 | 2011 |
| Induced pluripotent stem cell lines derived from equine fibroblasts K Nagy, HK Sung, P Zhang, S Laflamme, P Vincent, S Agha-Mohammadi, ... Stem Cell Reviews and Reports 7, 693-702, 2011 | 303 | 2011 |
| Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro A Tanaka, K Woltjen, K Miyake, A Hotta, M Ikeya, T Yamamoto, T Nishino, ... PloS one 8 (4), e61540, 2013 | 249 | 2013 |
| Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro A Tanaka, K Woltjen, K Miyake, A Hotta, M Ikeya, T Yamamoto, T Nishino, ... PloS one 8 (4), e61540, 2013 | 248 | 2013 |
| Efficient TALEN construction and evaluation methods for human cell and animal applications T Sakuma, S Hosoi, K Woltjen, K Suzuki, K Kashiwagi, H Wada, H Ochiai, ... Genes to Cells 18 (4), 315-326, 2013 | 239 | 2013 |
| The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis K Imamura, Y Izumi, A Watanabe, K Tsukita, K Woltjen, T Yamamoto, ... Science Translational Medicine 9 (391), eaaf3962, 2017 | 234 | 2017 |
| Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives F Oceguera-Yanez, SI Kim, T Matsumoto, GW Tan, L Xiang, T Hatani, ... Methods 101, 43-55, 2016 | 199 | 2016 |
| iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid β combination for Alzheimer’s disease T Kondo, K Imamura, M Funayama, K Tsukita, M Miyake, A Ohta, ... Cell reports 21 (8), 2304-2312, 2017 | 188 | 2017 |
| Capturing human trophoblast development with naive pluripotent stem cells in vitro S Io, M Kabata, Y Iemura, K Semi, N Morone, A Minagawa, B Wang, ... Cell stem cell 28 (6), 1023-1039. e13, 2021 | 180 | 2021 |
| Recapitulating the human segmentation clock with pluripotent stem cells M Matsuda, Y Yamanaka, M Uemura, M Osawa, MK Saito, A Nagahashi, ... Nature 580 (7801), 124-129, 2020 | 161 | 2020 |
| Evolutionarily distinctive transcriptional and signaling programs drive human germ cell lineage specification from pluripotent stem cells Y Kojima, K Sasaki, S Yokobayashi, Y Sakai, T Nakamura, Y Yabuta, ... Cell stem cell 21 (4), 517-532. e5, 2017 | 159 | 2017 |
| Cell-type-specific genome editing with a microRNA-responsive CRISPR–Cas9 switch M Hirosawa, Y Fujita, CJC Parr, K Hayashi, S Kashida, A Hotta, K Woltjen, ... Nucleic acids research 45 (13), e118-e118, 2017 | 109 | 2017 |
| Transient maternal IL-6 mediates long-lasting changes in neural stem cell pools by deregulating an endogenous self-renewal pathway D Gallagher, AA Norman, CL Woodard, G Yang, A Gauthier-Fisher, ... Cell stem cell 13 (5), 564-576, 2013 | 90 | 2013 |
| New strategies to generate induced pluripotent stem cells J O’Malley, K Woltjen, K Kaji Current Opinion in Biotechnology 20 (5), 516-521, 2009 | 89 | 2009 |
| Synthetic lateral inhibition governs cell-type bifurcation with robust ratios M Matsuda, M Koga, K Woltjen, E Nishida, M Ebisuya Nature communications 6 (1), 6195, 2015 | 88 | 2015 |
Andras NagySenior Scientist, Mount Sinai Hospital, Lunenfeld-Tanenbaum Research InstituteVerified email at lunenfeld.ca
